Product description

Insulin human isophane (recombinant)Dosage form: suspension for subcutaneous injections in 10 ml vials, 3 ml cartridges and pre-filled disposable insulin pen.

GEROPHARM’s insulin isophane is available on market since 2011.

·         Onset of action after subcutaneous administration – 1.5 hours
·         Maximum action – 4-12 hours in average
·         Duration of action – 24 hours in average
Read more

Specifications

Categories Biopharmaceuticals; BiopharmaceuticalsBiosimilars
Sales markets Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Russian Federation

More products from Geropharm

CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Lonza

Lonza

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Elevate your expectations. Demand more from your CDMO.

Elevate your expectations. Demand more from your CDMO.

CONTENT GROUP

CONTENT GROUP